Last reviewed · How we verify
NCT04182685
Evaluation of Medical Conditions Associated With Zika Virus Infection in Managua, Nicaragua
trial in Zika Virus in 410 participants. Completed in 31 December 2020.
31 December 2020
Quick facts
| Lead sponsor | RTI International |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 410 |
| Start date | 1 October 2019 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Nicaragua |
Conditions studied
- Zika Virus — all drugs for Zika Virus →
Sponsor
RTI International — full company profile →
Who can join
Adults 5 to 15, any sex, with Zika Virus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Zika virus (ZIKV) infection spread throughout the Americas with devastating consequences. Recent limited evidence suggests the potential for neurological effects associated with postnatally acquired ZIKV infection in humans; however, the impact on children is unknown. The researchers will conduct a longitudinal study of approximately 450 Nicaraguan children who were ages 2-12 in 2016 to evaluate the presence and persistence of neurological symptoms associated with ZIKV infection and to test whether ZIKV-infected children are at greater risk for developing neurological outcomes compared to uninfected children.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04182685
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other RTI International trials
Trials by the same sponsor.
- NCT07226401 — Virtual Village for Young Parents · NA · recruiting
- NCT06778278 — Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans · NA · recruiting
- NCT06927661 — ENSAND 2.0 Evaluation in Nigeria · NA · recruiting
- NCT06927674 — DELIVER Evaluation in Nigeria · NA · recruiting
- NCT05971888 — Better Dairy for All Evaluation in Ethiopia · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04182685 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RTI International
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04182685.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing